跳至主要内容
临床试验/NCT04662905
NCT04662905招募中不适用

A Prospective, Multicentre, Single-arm Feasibility Study Examining Novel Treatment Delivery of the Evoke Spinal Cord Stimulator (SCS) System to Treat Patients With Chronic Pain of the Trunk and/or Limbs

Saluda Medical Pty Ltd47 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2020年12月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200
试验地点
47
主要终点
Change in Evoke Compound Action Potentials (ECAPs) as measured by the Evoke SCS System

研究概览

简要总结

The purpose of this study is to test and evaluate novel treatment delivery of ECAP-controlled closed loop SCS through the incorporation of new software and/or hardware features for patients with the Evoke System.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 1. Subject has undergone trial implant or is planning to be implanted with the Evoke System within its approved indication.
  • 2. Subject is willing and capable of giving informed consent and able to comply with study-related requirements.

排除标准

  • 未提供

研究组 & 干预措施

ECAP-controlled, closed-loop SCS

Experimental

Spinal cord stimulation that measures and records evoked compound action potentials (ECAPs) and automatically adjusts the stimulation current to maintain a consistent ECAP amplitude

干预措施: Evoke Spinal Cord Stimulation (SCS) System (Device)

结局指标

主要结局

Change in Evoke Compound Action Potentials (ECAPs) as measured by the Evoke SCS System

时间窗: Through study completion, up to 2 years

次要结局

未报告次要终点

研究者

发起方
Saluda Medical Pty Ltd
申办方类型
Industry
责任方
Sponsor

研究点 (47)

Loading locations...

相似试验